A single administration of glucocorticoid increases exercise capacity in men with stable chronic obstructive pulmonary disease.
CONCLUSION: Our finding suggests that COPD patients experience improvements in exercise tolerance from a single high dose of glucocorticoid even in the stable phase of their disease.
FUNDING: none.
TRIAL REGISTRATION: EudraCT 2012-004503-13.
PMID: 30573004 [PubMed - in process]
Source: Danish Medical Journal - Category: General Medicine Tags: Dan Med J Source Type: research
More News: Chronic Obstructive Pulmonary | Denmark Health | General Medicine | Prednisolone | Respiratory Medicine | Spirometry | Sports Medicine | Study